Physician

Naseer Ahmad Humayun, MD

According to 2025 Medicare claims, Naseer Humayun, MD (NPI: 1932194719) practices internal medicine in the Dalton, GA market, with the plurality of this provider's patient population coming from Whitfield, GA. This provider's primary affiliated billing organization is PULMONARY AND SLEEP MEDICINE P C (NPI: 1265461172; TIN: 320068991) and primary practice location at 30720-5354.

Humayun's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 855 traditional Medicare patients, billed 3,934 HCPCS/CPT codes, and received $274,905 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 602 prescription claims across 150 beneficiaries totaling $1,131,447 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 4,204 claims. Open Payments data shows 49 records totaling $1,050. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $805,946 to $1,131,447. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $387,086 and ending at $220,506.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	931	5,083	$359,939
2016	1,014	4,859	$356,602
2017	1,052	5,533	$392,312
2018	1,037	6,083	$431,871
2019	1,098	6,926	$483,950
2020	979	5,226	$340,527
2021	991	5,786	$406,112
2022	993	5,517	$363,563
2023	979	4,827	$321,421
2024	855	3,934	$274,905

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	405	2,416	$805,946
2016	387	2,078	$759,823
2017	382	1,868	$844,410
2018	389	2,030	$1,119,015
2019	337	1,488	$861,601
2020	268	1,062	$924,000
2021	199	708	$1,166,885
2022	195	626	$1,049,690
2023	180	825	$1,260,783
2024	150	602	$1,131,447

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,968	6,074	$451,926
2016	1,584	5,058	$250,862
2017	1,499	4,408	$152,277
2018	1,713	5,085	$256,166
2019	2,094	5,798	$257,862
2020	2,344	7,304	$406,622
2021	2,065	6,222	$349,249
2022	1,860	5,499	$293,498
2023	1,765	5,373	$405,136
2024	1,461	4,204	$277,839

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	480	877	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	392	611	$60
94729	Test to examine how well the lungs exchange gases	385	403	$35
94727	Test to determine lung volumes using gas dilution or washout	384	402	$29
94060	Test to measure expiratory airflow and volume changes before and after medication administration	386	404	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	16	480	$204,002
Zemaira	Alpha-1-Proteinase Inhibitor	13	364	$201,612
Lumryz	Sodium Oxybate	12	360	$148,223
Xywav	Sodium,calcium,mag,pot Oxybate	12	360	$123,440
Xembify	Immune Globulin,gamma(Igg)klhw	13	364	$92,623

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	86	652	$47,569
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	12	$33,916
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	27	$27,461
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	30	$22,971
A7030	Full face mask used with positive airway pressure device, each	N	113	267	$21,866

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$1,050	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Naseer Ahmad Humayun, MD?

Tedicare shows public-source Medicare data for Naseer Ahmad Humayun, MD (NPI 1932194719), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Naseer Ahmad Humayun, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Naseer Ahmad Humayun, MD?

Naseer Ahmad Humayun, MD is linked to PULMONARY AND SLEEP MEDICINE P C (billing NPI 1265461172) in the available physician profile data.

Does Naseer Ahmad Humayun, MD have Open Payments data?

Naseer Ahmad Humayun, MD has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.